1245492

Mimi Kim, M.D. — FEI 3031224812

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 25, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Los Angeles, CA (United States)

Additional Details

Clinical Investigator (CI)